BARDA DRIVe EZ-BAA-22-100-SOL-00003
- Response deadline
- Oct 18, 2027 Due in 358 days
- Date posted
- Oct 18, 2022
- Source
- Open notice
Description
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. _______ Amendment 001: This amendment to the EZBAA hereby opens the following research areas of interest ("AOI"). Please review the amendment for details of each AOI, including closing dates: AOI #15: ReDIRECT AOI #16: Lab at Home AOI #17: Digital MCMs AOI #18: Host-Directed Therapeutics AOI #19: Healing Lungs AOI #20: DRIVe Forward AOI #21: Vaccines on Demand AOI #22: ReBooT AOI #23: Host-Based Diagnostics _____
Classifications
Documents
No documents posted for this opportunity.
Contacts
Similar contracts
- Quantitative Analysis of Longitudinal MR ImagesMarylandDue Nov 9, 2026
- ARPA-H Emerging Health Innovators (EHI) InitiativeDistrict of ColumbiaDue Feb 10, 2027
- Q--Amplicon Sequencing ServicesDue Nov 5, 2026
- Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
- Development/Production - Kidney GEC-Specific AAV VectorMODue Nov 4, 2026
- Pre-Clinical Models of Infectious DiseasesDue Dec 7, 2026